Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Asperen, CJ" or (type any "bookEditor issueEditor" and editor="Van Asperen, CJ")

Add to list
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, Frederieke H van der Baan, Andrew Berchuck, Sharon E Johnatty, Katja K Aben, Bjarni A Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L Andrulis, Hoda Anton-Culver, et al.

(2016) GYNECOLOGIC ONCOLOGY. 141(2). p.386-401
Add to list
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

Kim De Leeneer (UGent) , Mieke Van Bockstal (UGent) , Sara De Brouwer (UGent) , Natalia Swietek (UGent) , Peter Schietecatte (UGent) , N Sabbaghian, J Van den Ende, S Willocx, K Storm, B Blaumeiser, et al.

(2012) BREAST CANCER RESEARCH AND TREATMENT. 133(1). p.393-398
Add to list
- Journal Article
- A1
- open access
Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

A Jakubowska, D Rozkrut, A Antoniou, U Hamann, RJ Scott, L McGuffog, S Healy, OM Sinilnikova, G Rennert, F Lejbkowicz, et al.

(2012) BRITISH JOURNAL OF CANCER. 106(12). p.2016-2024
Add to list
Evaluation of RAD51C as a new breast cancer suceptibility gene in Belgian/Dutch population

Kim De Leeneer (UGent) , M Van Bockstael, Natalia Swietek (UGent) , J Van den Ende, K Storm, B Blaumeiser, K Leunens, CJ van Asperen, JT Wijnen, E Legius, et al.

(2011) EUROPEAN JOURNAL OF HUMAN GENETICS. 19(suppl. 2). p.195-195

Academic Bibliography

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

Evaluation of RAD51C as a new breast cancer suceptibility gene in Belgian/Dutch population

Contents

Support

Contact